Number of Positions per Year: 1
Prior Education/Training Requirements
Completion of MD degree and internship training
Residents are generally selected from candidates invited to interview for our residency program. The application deadline for our residency program is October 12, 2012 (through ERAS). Applying for the Three-Year Residency Program through ERAS does not exclude the applicant from this program.
Description of Training Program
The Cutaneous Oncology Program, under the direction of Drs. Alain Rook, Ellen Kim and Carmela Vittorio, was initiated at the University of Pennsylvania in 1987. This program represents the initial year of a four year residency within the Department of Dermatology. During this initial year, the trainee works side by side with leaders in the field of Cutaneous Lymphoma and Malignant Melanoma. Expertise is developed in the diagnosis and management of all stages of cutaneous T-cell lymphomas, with special emphasis placed on the use of immune response modifiers including photopheresis, cytokines (interferons and interleukins), and retinoids. The Cutaneous Lymphoma Program is also a major referral center for cutaneous B-cell lymphomas. Participation in the Lymphoma program's patient oriented and laboratory based research efforts are encouraged. Clinical trials of novel therapeutic agents are typically ongoing at any given time. The resident also participates in regularly scheduled Pigmented Lesion Group clinics with the resultant opportunity to gain expertise in the diagnosis and treatment of melanoma and dysplastic nevi of all types. The resident should receive adequate training and be provided with the requisite skills and expertise to pursue an academic career in patient oriented research in cutaneous oncology upon conclusion of the remaining years of the Dermatology Residency Program. This is a matched program.Program Directors Alain Rook, MD
Ellen Kim, MD
Carmela Vittorio, MD
Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
Philadelphia, PA 19104